Unnamed: 0,title,date,stock,sentiment
447578.0,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,2020-06-01 16:00:00-04:00,EVOK,neutral
447579.0,"The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas",2020-05-27 07:25:00-04:00,EVOK,positive
447580.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-26 10:32:00-04:00,EVOK,neutral
447581.0,71 Biggest Movers From Friday,2020-05-26 04:30:00-04:00,EVOK,neutral
447582.0,"The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",2020-05-21 08:01:00-04:00,EVOK,neutral
447583.0,Stocks That Hit 52-Week Highs On Wednesday,2020-05-20 10:38:00-04:00,EVOK,neutral
447584.0,Evoke Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA Resubmission,2020-05-20 08:30:00-04:00,EVOK,positive
447585.0,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",2020-05-20 08:12:00-04:00,EVOK,neutral
447586.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-19 10:43:00-04:00,EVOK,neutral
447587.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,EVOK,positive
447588.0,Evoke Pharma Q1 EPS $(0.070) Up From $(0.110) YoY,2020-05-12 08:33:00-04:00,EVOK,neutral
447589.0,Evoke Pharma Q4 EPS $(0.06) Up From $(0.1) YoY,2020-03-12 08:42:00-04:00,EVOK,neutral
447590.0,Evoke Pharma Receives Notice Of Allowance From USPTO For Gimoti,2020-01-27 08:31:00-05:00,EVOK,neutral
447591.0,14 Drug Manufacturers—Specialty & Generic Stocks Moving In Thursday's Session,2020-01-23 12:52:00-05:00,EVOK,neutral
447592.0,"Evoke Pharma And Novos Growth Partners Mutually Agreed To Terminate Commercialization Agreement Dated Jan. 5, 2019",2020-01-23 08:33:00-05:00,EVOK,positive
447593.0,Evoke Pharma Enters Commercialization Agreement With EVERSANA Life Sciences For Gimoti,2020-01-23 08:32:00-05:00,EVOK,positive
447594.0,18 Drug Manufacturers—Specialty & Generic Stocks Moving In Wednesday's Session,2020-01-22 13:28:00-05:00,EVOK,neutral
447595.0,116 Healthcare Stocks Moving In Wednesday's Session,2020-01-22 12:37:00-05:00,EVOK,neutral
447596.0,FDA Accepts Evoke Pharma's NDA Resubmission For Gimoti,2020-01-21 08:35:00-05:00,EVOK,positive
447597.0,Evoke Resubmits Gimoti New Drug Application To FDA,2019-12-20 08:32:00-05:00,EVOK,neutral
447598.0,Evoke Pharma Regains Compliance With Nasdaq Minimum Bid Requirement,2019-12-02 08:35:00-05:00,EVOK,neutral
447599.0,Evoke Pharma Granted 180-Day Extension By Nasdaq Regarding Minimum Bid Price,2019-11-13 08:30:00-05:00,EVOK,positive
447600.0,Evoke Pharma Earlier Reported Q3 EPS $(0.07) Up From $(0.09) YoY,2019-11-07 09:52:00-05:00,EVOK,neutral
447601.0,Evoke Pharma Reports Completion Of Manufacturing Of Commercial-Scale Registration Batches Of Gimoti,2019-09-17 08:39:00-04:00,EVOK,neutral
447602.0,18 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-08-30 08:43:00-04:00,EVOK,neutral
447603.0,50 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-08 21:56:00-04:00,EVOK,neutral
447604.0,25 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-08 08:35:00-04:00,EVOK,neutral
447605.0,28 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-08-01 04:20:00-04:00,EVOK,neutral
447606.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-31 09:41:00-04:00,EVOK,neutral
447607.0,45 Healthcare Stocks Moving In Monday's After-Market Session,2019-07-30 04:54:00-04:00,EVOK,neutral
447608.0,30 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-29 09:35:00-04:00,EVOK,neutral
447609.0,40 Healthcare Stocks Moving In Friday's After-Market Session,2019-07-29 04:25:00-04:00,EVOK,neutral
447610.0,30 Healthcare Stocks Moving In Thursday's After-Market Session,2019-07-26 04:36:00-04:00,EVOK,neutral
447611.0,Biotech Stock On The Radar: Evoke Pharma Sets Date With FDA,2019-07-25 12:58:00-04:00,EVOK,neutral
447612.0,35 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-07-25 05:55:00-04:00,EVOK,neutral
447613.0,62 Biggest Movers From Yesterday,2019-06-28 05:20:00-04:00,EVOK,neutral
447614.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-06-27 12:41:00-04:00,EVOK,neutral
447615.0,Evoke Pharma shares are trading higher after the company requested a Type A FDA meeting to plan for the resubmission of Gimoti NDA.,2019-06-27 10:54:00-04:00,EVOK,positive
447616.0,Evoke Pharma Reports Requested Type-A FDA Meeting To Plan For Resubmission Of Gimoti New Drug Application,2019-06-27 08:36:00-04:00,EVOK,neutral
447617.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,EVOK,positive
447618.0,"The Daily Biotech Pulse: FibroGen Kidney Disease Trial Disappoints, Medtronic To Buy Titan Spine, Puma's Weak Breast Cancer Drug Sales",2019-05-10 08:00:00-04:00,EVOK,negative
447619.0,Evoke Pharma Q1 EPS $(0.11) Misses $(0.07) Estimate,2019-05-08 17:07:00-04:00,EVOK,negative
447620.0,"The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug",2019-04-11 07:48:00-04:00,EVOK,positive
447621.0,"The Daily Biotech Pulse: Amgen's Bone-Building Osteoporosis Drug Clears FDA Muster, PhaseBio Offering",2019-04-10 07:32:00-04:00,EVOK,positive
447622.0,"The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing",2019-04-09 08:10:00-04:00,EVOK,neutral
447623.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts",2019-04-07 17:04:00-04:00,EVOK,neutral
447624.0,"The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership",2019-04-05 07:48:00-04:00,EVOK,positive
447625.0,"The Daily Biotech Pulse: Recro Restructures, Biotechs Raise Proceeds In Droves, Silk Road, NGM Biopharma To Debut",2019-04-04 07:58:00-04:00,EVOK,neutral
447626.0,"The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings",2019-04-03 08:19:00-04:00,EVOK,positive
447627.0,54 Biggest Movers From Yesterday,2019-04-03 05:42:00-04:00,EVOK,neutral
447628.0,Mid-Afternoon Market Update: ADMA Biologics Jumps On FDA Nod For Immunodeficiency Therapy; Evoke Pharma Shares Plummet,2019-04-02 14:38:00-04:00,EVOK,positive
447629.0,Mid-Day Market Update: Crude Oil Up Over 1%; Apyx Medical Shares Slide,2019-04-02 12:38:00-04:00,EVOK,negative
447630.0,51 Stocks Moving In Tuesday's Mid-Day Session,2019-04-02 12:27:00-04:00,EVOK,neutral
447631.0,Mid-Morning Market Update: Markets Edge Lower; Walgreens Misses Q2 Views,2019-04-02 10:12:00-04:00,EVOK,negative
447632.0,32 Stocks Moving In Tuesday's Pre-Market Session,2019-04-02 08:20:00-04:00,EVOK,neutral
447633.0,A Peek Into The Markets: US Stock Futures Flat Ahead Of Durable-Goods Orders Data,2019-04-02 07:27:00-04:00,EVOK,neutral
447634.0,Evoke Pharma shares are trading lower after the company received a complete response letter from the FDA addressing deficiencies in its New Drug Application for Gimoti.,2019-04-02 06:21:00-04:00,EVOK,neutral
447635.0,Evoke Pharma Receives CRL from FDA with Recommendations to Address Deficiencies for Gimoti NDA,2019-04-02 06:03:00-04:00,EVOK,neutral
447636.0,"Benzinga Pro's Top 8 Most-Searched Tickers For Morning Of Monday, Apr. 1, 2019",2019-04-01 09:49:00-04:00,EVOK,positive
447637.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs",2019-03-30 09:32:00-04:00,EVOK,neutral
447638.0,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,2019-03-29 12:45:00-04:00,EVOK,neutral
447639.0,71 Biggest Movers From Yesterday,2019-03-15 05:24:00-04:00,EVOK,neutral
447640.0,Evoke Pharma Reports Submission To FDA Review Letter For Gimoti New Drug Application,2019-03-14 16:45:00-04:00,EVOK,neutral
447641.0,56 Stocks Moving In Thursday's Mid-Day Session,2019-03-14 12:24:00-04:00,EVOK,neutral
447642.0,"Evoke Pharma shares are trading higher after the FDA granted the company its requested pre-PDUFA date meeting to be held on March 21, 2019.",2019-03-14 10:32:00-04:00,EVOK,positive
447643.0,"UPDATE: Evoke Pharma Says FDA Granted Pre-PDUFA Date Meeting, Will Be Held On Mar. 21, 2019",2019-03-14 08:37:00-04:00,EVOK,positive
447644.0,"Evoke Pharma 8-K Shows Co. Submitted Response To FDA's Multi-Disciplinary Review Letter Related To Gimoti 505 New Drug Application; Co. Requested FDA Meeting Prior To Apr. 1, 2019 PDUFA Date",2019-03-14 08:36:00-04:00,EVOK,neutral
447645.0,Evoke Pharma Q4 EPS $(0.10) Misses $(0.09) Estimate,2019-03-06 08:31:00-05:00,EVOK,negative
447646.0,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",2019-03-06 07:39:00-05:00,EVOK,negative
447647.0,"Benzinga's Top Upgrades, Downgrades For March 5, 2019",2019-03-05 09:12:00-05:00,EVOK,positive
447648.0,H.C. Wainwright Downgrades Evoke Pharma to Neutral,2019-03-05 08:03:00-05:00,EVOK,neutral
447649.0,"The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings",2019-03-05 07:24:00-05:00,EVOK,positive
447650.0,62 Biggest Movers From Yesterday,2019-03-05 05:19:00-05:00,EVOK,neutral
447651.0,Mid-Afternoon Market Update: Nightstar Therapeutics Surges On Acquisition News; Evoke Pharma Shares Plunge,2019-03-04 14:34:00-05:00,EVOK,positive
447652.0,50 Stocks Moving In Monday's Mid-Day Session,2019-03-04 12:44:00-05:00,EVOK,neutral
447653.0,Mid-Day Market Update: U.S. Stocks Turn Negative; Dow Down Over 350 Points,2019-03-04 12:29:00-05:00,EVOK,negative
447654.0,Mid-Morning Market Update: Markets Open Higher; Childrens Place Misses Q4 Expectations,2019-03-04 10:38:00-05:00,EVOK,negative
447655.0,Evoke Pharma shares are trading lower after the company received a DR letter from the FDA on its Gimoti New Drug Application; the letter describes concerns in three sections of the NDA.,2019-03-04 09:25:00-05:00,EVOK,neutral
447656.0,Evoke Pharma Receives DR Letter From FDA Communication On Gimoti NDA; Letter describes Concerns In Three Sections Of NDA,2019-03-04 08:31:00-05:00,EVOK,neutral
447657.0,"Evoke Pharma Shares Halted, News Pending",2019-03-04 08:27:00-05:00,EVOK,positive
447658.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-03-03 09:41:00-05:00,EVOK,neutral
447659.0,Evoke Pharma Signs Commercial And Financial Agreement For Its Lead Product Gimoti In The US Novos Growth Partners,2019-01-07 08:52:00-05:00,EVOK,positive
447660.0,Evoke Pharma Q3 EPS $(0.09) Misses $(0.08) Estimate,2018-11-13 16:27:00-05:00,EVOK,negative
447661.0,31 Stocks Moving In Thursday's Mid-Day Session,2018-08-16 12:26:00-04:00,EVOK,neutral
447662.0,Mid-Morning Market Update: Markets Open Higher; Walmart Tops Q2 Expectations,2018-08-16 10:15:00-04:00,EVOK,positive
447663.0,"Evoke Pharma's Gimoti NDA Accepted for FDA Review; Sets April 1, 2019 As PDUFA Target Goal Date",2018-08-16 08:33:00-04:00,EVOK,positive
447664.0,Evoke Pharma Q2 EPS $(0.14) Beats $(0.17) Estimate,2018-08-09 16:14:00-04:00,EVOK,neutral
447665.0,Evoke Submits an NDA for Gimoti to the FDA,2018-06-04 07:39:00-04:00,EVOK,neutral
447666.0,Evoke Pharma Q1 EPS $(0.13) Beats $(0.19) Estimate,2018-05-14 06:31:00-04:00,EVOK,neutral
447667.0,Evoke Pharma Shares Up 2.1%; Earlier Co. Announced Receipt Of Mexican Patent for Gimoti,2018-05-10 09:46:00-04:00,EVOK,positive
447668.0,Sphera Funds Reports 9.11% Stake In Evoke Pharma,2018-05-08 11:38:00-04:00,EVOK,neutral
447669.0,"Evoke Granted First Gender Specific Patent for Gimoti, European Union Patent Applies to 38 Member States With Expiry Extended to 2032",2018-04-30 07:31:00-04:00,EVOK,positive
447670.0,17 Stocks Moving In Monday's Pre-Market Session,2018-03-26 08:06:00-04:00,EVOK,neutral
447671.0,Evoke and Mallinckrodt Amend Milestone Payments,2018-03-26 07:33:00-04:00,EVOK,neutral
447672.0,Evoke Pharma Reports Q4 EPS $(0.02) vs $(0.12) In Same Qtr. Last Year,2018-03-07 17:21:00-05:00,EVOK,neutral
447673.0,"Evoke Pharma's $2.4M PDUFA Fee is Waved by the FDA for Gimoti, Plans to File NDA in Q2 2018",2018-03-05 07:34:00-05:00,EVOK,neutral
447674.0,46 Biggest Movers From Yesterday,2018-02-16 05:19:00-05:00,EVOK,neutral
447675.0,Evoke Pharma Reports Discovery Of Sex-Based Pharmacokinetic Differences For Gimoti,2018-02-15 07:36:00-05:00,EVOK,neutral
447676.0,Evoke Pharma Earlier Amended 13G Filing From LVP Life Science Ventures Showed 10.28% Stake,2018-01-16 10:44:00-05:00,EVOK,neutral
447677.0,"Evoke Pharma Reports Q3 EPS $(0.34) vs. $(0.29) In Same Qtr. Last Year, No Sales",2017-11-14 17:38:00-05:00,EVOK,negative
447678.0,Evoke Pharma Files For $100M Mixed Shelf Offering,2017-11-14 16:59:00-05:00,EVOK,neutral
447679.0,Evoke Pharma Shares Up 6.2% Following Signing Of Commercial Deal With Thermo Fisher's Patheon Unit For Gimoti,2017-11-09 08:42:00-05:00,EVOK,positive
447680.0,"Evoke Pharma Says Will Host Conference Call To Review Successful Results Of Comparative Exposure Pharmacokinetic Study For Gimoti On Tues., Oct. 31 At 9 a.m. EDT",2017-10-27 08:31:00-04:00,EVOK,positive
447681.0,35 Biggest Movers From Yesterday,2017-10-24 05:18:00-04:00,EVOK,neutral
447682.0,32 Stocks Moving In Monday's Mid-Day Session,2017-10-23 12:31:00-04:00,EVOK,neutral
447683.0,25 Stocks Moving In Monday's Pre-Market Session,2017-10-23 08:03:00-04:00,EVOK,neutral
447684.0,Evoke Pharma Announces 'Positive' Topline Results from Comparative Exposure Pharmacokinetic Study for Gimoti,2017-10-23 07:34:00-04:00,EVOK,neutral
447685.0,"FBR Capital Reinstates Buy on Evoke Pharma, Announces $10.00",2017-10-19 08:23:00-04:00,EVOK,neutral
447686.0,"Seaport Global Initiates Coverage On Evoke Pharma with Buy Rating, Announces $10.00 Price Target",2017-10-06 09:56:00-04:00,EVOK,neutral
447687.0,"Evoke Pharma Completes Dosing For Gimoti Compartive Study, Data Expected In Q4",2017-09-12 08:31:00-04:00,EVOK,neutral
447688.0,Evoke Pharma Reports Q2 EPS $(0.11) vs $(0.15) Est.,2017-08-14 16:06:00-04:00,EVOK,neutral
447689.0,Evoke Pharma Reports Initiation Of Comparative Exposure Pharmacokinetic Study For Gimoti,2017-08-14 08:33:00-04:00,EVOK,neutral
447690.0,Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti By Late 2017 or Early 2018,2017-05-31 08:32:00-04:00,EVOK,positive
447691.0,Evoke Pharma Reports Q1 EPS $(0.37) vs $(0.17) Est.,2017-05-15 16:05:00-04:00,EVOK,neutral
447692.0,"Evoke Pharma Presents Phase 3 Trial Data For Gimoti, Patients Responded Better To Gimoti Than Placebo With Statistical Significance; Co. Expects To File NDA With The FDA",2017-05-10 08:33:00-04:00,EVOK,positive
447693.0,Evoke Pharma Reports Collaboration with Spaulding Clinical Research for Gimoti Comparative Exposure Pharmacokinetic Trial,2017-04-18 08:36:00-04:00,EVOK,neutral
447694.0,Evoke Pharma Reports Type A Meeting with FDA Confirmed Acceptability of Evoke Pharma's Proposed Comparative Exposure PK Trial for Gimoti NDA,2017-04-04 08:32:00-04:00,EVOK,positive
447695.0,Evoke Pharma Reports Q4 EPS $(0.12) vs $(0.19) Est.,2017-03-15 16:12:00-04:00,EVOK,neutral
447696.0,Evoke Pharma Pops to High of $3.49 on Volume,2017-02-21 12:25:00-05:00,EVOK,neutral
447697.0,Evoke Pharma Spikes to High of $3.15 on Volume,2017-02-17 15:43:00-05:00,EVOK,neutral
447698.0,22 Biggest Mid-Day Losers For Thursday,2017-02-16 12:54:00-05:00,EVOK,negative
447699.0,Evoke Pharma Announces Pricing of Public Offering of 2.41M Common Stock At $2.90/Share,2017-02-16 08:46:00-05:00,EVOK,neutral
447700.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-02-16 08:17:00-05:00,EVOK,neutral
447701.0,15 Biggest Mid-Day Gainers For Wednesday,2017-02-15 12:43:00-05:00,EVOK,neutral
447702.0,Mid-Day Market Update: Dow Rises 70 Points; Fossil Shares Drop Following Q4 Results,2017-02-15 12:12:00-05:00,EVOK,neutral
447703.0,Mid-Morning Market Update: Markets Mostly Flat; PepsiCo Profit Beats Estimates,2017-02-15 10:18:00-05:00,EVOK,positive
447704.0,Evoke Pharma Reports FDA Exempted Co. from Requirement for Human Factor Validation Study,2017-02-15 08:33:00-05:00,EVOK,neutral
447705.0,Hearing Evoke Pharma Upgraded At Laidlaw,2017-01-30 12:54:00-05:00,EVOK,neutral
447706.0,Evoke Pharma Pops to High of $2.56 on Volume,2017-01-30 12:51:00-05:00,EVOK,neutral
447707.0,15 Biggest Mid-Day Gainers For Thursday,2017-01-05 12:38:00-05:00,EVOK,neutral
447708.0,8 Biggest Price Target Changes For Thursday,2017-01-05 09:44:00-05:00,EVOK,neutral
447709.0,25 Stocks Moving In Thursday's Pre-Market Session,2017-01-05 08:23:00-05:00,EVOK,neutral
447710.0,"Rodman & Renshaw Upgrades Evoke Pharma to Buy, Raises Target to $6.00",2017-01-05 07:16:00-05:00,EVOK,neutral
447711.0,Mid-Afternoon Market Update: NASDAQ Gains Over 50 Points; Evoke Pharma Shares Spike Higher,2017-01-04 14:41:00-05:00,EVOK,positive
447712.0,18 Biggest Mid-Day Gainers For Wednesday,2017-01-04 12:39:00-05:00,EVOK,neutral
447713.0,Mid-Day Market Update: Crude Oil Up Over 1%; Agile Therapeutics Shares Slide,2017-01-04 12:13:00-05:00,EVOK,negative
447714.0,Mid-Morning Market Update: Markets Open Higher; UniFirst Posts Lower Q1 Profit,2017-01-04 10:08:00-05:00,EVOK,positive
447715.0,"Evoke Pharma Shares Up 48%; Co Earlier Announced Phase 3 Gimoti Trial Data Showing Primary Endpoint Not Met, 51% Of Patients Responded Better To Gimoti Than Placebo",2017-01-04 09:23:00-05:00,EVOK,positive
447716.0,15 Stocks Moving In Wednesday's Pre-Market Session,2016-12-28 08:09:00-05:00,EVOK,neutral
447717.0,12 Biggest Mid-Day Losers For Monday,2016-12-19 13:10:00-05:00,EVOK,negative
447718.0,Mid-Morning Market Update: Markets Open Higher; Adobe Beats Q4 Expectations,2016-12-16 09:40:00-05:00,EVOK,neutral
447719.0,15 Stocks Moving In Friday's Pre-Market Session,2016-12-16 08:42:00-05:00,EVOK,neutral
447720.0,Evoke Pharma Trading Up 37+% PreMarket After Announcing Positive NDA Guidance After Close Thursday,2016-12-16 08:42:00-05:00,EVOK,positive
447721.0,Evoke Receives Positive NDA Submission Guidance from US FDA for Gimoti,2016-12-15 16:09:00-05:00,EVOK,positive
447722.0,Evoke Pharma Reports Q3 EPS $(0.29) vs. Est. $(0.26),2016-11-09 17:19:00-05:00,EVOK,neutral
447723.0,18 Stocks Moving In Wednesday's Pre-Market Session,2016-09-28 08:21:00-04:00,EVOK,neutral
447724.0,18 Biggest Mid-Day Gainers For Wednesday,2016-09-07 12:58:00-04:00,EVOK,neutral
447725.0,Evoke Pharma Reports Positive Non-Clinical Pre-NDA Meeting with FDA Related to Gimoti,2016-09-07 08:33:00-04:00,EVOK,positive
447726.0,20 Biggest Mid-Day Losers For Tuesday,2016-08-16 13:23:00-04:00,EVOK,negative
447727.0,"After-Hours Losers Aug. 15, '16: HAIN Down 25%, HTBX 17%, EVOK 7%, DAVE 3%, GBDC 2.7%, CXO 1.8%, ALRM 1.3%",2016-08-15 17:59:00-04:00,EVOK,negative
447728.0,Evoke Pharmaceuticals Reports Q2 Loss/Share $(0.41) vs Est Loss/Share $(0.43),2016-08-15 16:32:00-04:00,EVOK,neutral
447729.0,"UPDATE: Evoke Pharma Shares Down 1% for Session, Had Traded as High as $4 Earlier Today",2016-07-29 15:24:00-04:00,EVOK,positive
447730.0,Evoke Pharma Resumes Trading after CB Halt; Falls to Low of $3.14,2016-07-29 15:21:00-04:00,EVOK,negative
447731.0,Evoke Pharma Shares Selloff Following Offering Announcement,2016-07-29 15:17:00-04:00,EVOK,positive
447732.0,"Evoke Pharma Shares Halted on Circuit Breaker, Sink, Still Up 11% for Session",2016-07-29 15:16:00-04:00,EVOK,positive
447733.0,Evoke Pharma Reports $10M Registered Direct ATM Offering,2016-07-29 15:16:00-04:00,EVOK,neutral
447734.0,Evoke Pharma Announces $10 Million Registered Direct Offering Priced At-The-Market,2016-07-29 15:15:00-04:00,EVOK,neutral
447735.0,20 Biggest Mid-Day Gainers For Friday,2016-07-29 13:11:00-04:00,EVOK,neutral
447736.0,Empery Asset Management Reports 6.65% Stake in Evoke Pharma in 13G,2016-07-29 07:07:00-04:00,EVOK,positive
447737.0,20 Biggest Mid-Day Gainers For Thursday,2016-07-28 12:50:00-04:00,EVOK,neutral
447738.0,"After-Hours Gainers: STB Up 33%, OCN 28%, PCMI 26%, GRPN 22%, CRUS 14%, SEIC 12.5%, EVOK 11.7%, ASPS 9%, ARRS 8.8%, MOH 8.7%, MKSI 8.3%",2016-07-27 18:43:00-04:00,EVOK,neutral
447739.0,Intracoastal Capital Reports 4.99% Passive Stake In Evoke Pharma in 13G,2016-07-27 16:12:00-04:00,EVOK,positive
447740.0,Evoke Pharma Receives Conditional FDA Acceptance of Proposed Brand Name for EVK-001,2016-07-26 08:31:00-04:00,EVOK,positive
447741.0,Importance Of Phase III Trials,2016-07-25 09:50:00-04:00,EVOK,positive
447742.0,10 Biggest Mid-Day Losers For Wednesday,2016-07-20 12:54:00-04:00,EVOK,negative
447743.0,Stocks Hitting 52-Week Lows,2016-07-20 10:18:00-04:00,EVOK,negative
447744.0,Evoke Pharma Reports $4.5M ATM Offering,2016-07-20 07:31:00-04:00,EVOK,neutral
447745.0,11 Biggest Mid-Day Losers For Tuesday,2016-07-19 12:55:00-04:00,EVOK,negative
447746.0,Benzinga's Top Downgrades,2016-07-19 09:04:00-04:00,EVOK,positive
447747.0,Noble Financial  Downgrades Evoke Pharma to Hold,2016-07-19 07:34:00-04:00,EVOK,positive
447748.0,Northland Capital Downgraded Evoke Pharma Shares from Outperform to Market Perform,2016-07-18 16:58:00-04:00,EVOK,positive
447749.0,"Tale Of The Technicals: Notable Price Action In Apple, Evoke And Microsoft",2016-07-18 16:38:00-04:00,EVOK,neutral
447750.0,Mid-Afternoon Market Update: Evoke Pharma Drops On Failed Phase 3 EVK-001 Data; ParkerVision Shares Spike Higher,2016-07-18 14:37:00-04:00,EVOK,negative
447751.0,Technical Alert: Evoke Pharma Goes From Two-Year High To All-Time Low In A Day,2016-07-18 13:30:00-04:00,EVOK,neutral
447752.0,12 Biggest Mid-Day Losers For Monday,2016-07-18 13:16:00-04:00,EVOK,negative
447753.0,Mid-Day Market Update: ARM Holdings Surges On Softbank Acquisition; Ferro Shares Slide,2016-07-18 12:17:00-04:00,EVOK,positive
447754.0,"Rodman & Renshaw Downgrades Evoke Pharma to Neutral, Lowers PT to $2.00",2016-07-18 11:23:00-04:00,EVOK,negative
447755.0,"Evoke Pharma Plunges 70%, Prompting Brean To Downgrade The Stock From Buy",2016-07-18 11:22:00-04:00,EVOK,neutral
447756.0,Brean Capital Downgrades Evoke Pharma to Hold,2016-07-18 10:52:00-04:00,EVOK,neutral
447757.0,Mid-Morning Market Update: Markets Mostly Higher; Bank of America Tops Q2 Expectations,2016-07-18 10:07:00-04:00,EVOK,positive
447758.0,Evoke Pharma's Phase 3 Clinical Trial Of EVK-001 Fails To Achieve Primary Endpoint,2016-07-18 09:25:00-04:00,EVOK,negative
447759.0,Evoke Pharma Shares Down 72% At $2.95/Share,2016-07-18 08:40:00-04:00,EVOK,positive
447760.0,Evoke Pharma Shares Fall Sharply To $5.25/Share Pre-market on Failed Phase 3 EVK-001 Data,2016-07-18 08:36:00-04:00,EVOK,negative
447761.0,Evoke Pharma Misses EVK-001 Primary Endpoint,2016-07-18 08:31:00-04:00,EVOK,negative
447762.0,Evoke Advances Commercial Preparations for EVK-001 with inVentiv Agreement,2016-07-07 08:31:00-04:00,EVOK,positive
447763.0,Evoke Pharma Reports Q1 EPS $(0.45) Vs Est $(0.41),2016-05-11 16:05:00-04:00,EVOK,neutral
447764.0,Evoke Announces Timing of Phase 3 Results from its Recently Fully Enrolled Pivotal Clinical Trial of EVK-001,2016-05-03 07:35:00-04:00,EVOK,neutral
447765.0,Benzinga's Top Initiations,2016-03-16 09:26:00-04:00,EVOK,positive
447766.0,Northland Securities Initiates Coverage on Evoke Pharma at Outperform,2016-03-16 07:11:00-04:00,EVOK,positive
447767.0,"Ascendiant Capital Maintains Buy on Evoke Pharma, Raises PT to $12.00",2016-03-14 07:01:00-04:00,EVOK,neutral
447768.0,Evoke Nears Completion of Phase 3 Clinical Trial Enrollment and Secures Extension to Credit Facility,2016-03-01 08:31:00-05:00,EVOK,positive
447769.0,Evoke Pharma to Show Results From Successful Thorough ECG Study of EVK-001 at Digestive Disease Week 2016,2016-02-17 08:34:00-05:00,EVOK,positive
447770.0,FBR Capital Assumes Evoke Pharma at Outperform,2016-02-17 06:51:00-05:00,EVOK,neutral
447771.0,Evoke Pharma Reports Q3 EPS $(0.42) Vs Est $(0.54),2015-11-12 16:08:00-05:00,EVOK,neutral
447772.0,Evoke Pharma Spikes to High on Volume,2015-10-07 12:58:00-04:00,EVOK,neutral
447773.0,Evoke Pharma Spikes to High on Volume,2015-10-05 10:12:00-04:00,EVOK,neutral
447774.0,Morning Market Gainers,2015-10-01 09:43:00-04:00,EVOK,neutral
447775.0,"H.C. Wainwright Initiates Coverage on Evoke Pharma at Buy, Announces $27.00 PT",2015-10-01 07:24:00-04:00,EVOK,neutral
447776.0,Morning Market Gainers,2015-09-15 09:44:00-04:00,EVOK,neutral
447777.0,U.S. Food and Drug Administration's (FDA) Draft Guidance is Consistent With Evoke's Current Phase 3 Study Design and Endpoint for EVK-001,2015-09-15 08:32:00-04:00,EVOK,neutral
447778.0,Benzinga's Top Initiations,2015-08-20 09:55:00-04:00,EVOK,positive
447779.0,Brean Sees 200+% Upside In Shares Of Evoke Pharma,2015-08-20 09:32:00-04:00,EVOK,positive
447780.0,"Brean Capital Initiates Coverage on Evoke Pharma at Buy, Announces $13.00 PT",2015-08-20 05:04:00-04:00,EVOK,neutral
447781.0,"Mid-Day Market Update: Tuesday's Movers, China's Growth Worries And More",2015-08-18 11:59:00-04:00,EVOK,negative
447782.0,Morning Market Gainers,2015-08-18 09:38:00-04:00,EVOK,neutral
447783.0,Evoke Gets Favorable Response From U.S.FDA Regarding Pediatric Study Plan for EVK-001,2015-08-18 08:30:00-04:00,EVOK,positive
447784.0,Evoke Pharma reports Q2 Loss of $0.52/Share vs Loss of $0.60/Share Est.,2015-08-13 16:08:00-04:00,EVOK,negative
447785.0,Evoke Pharma Reports Publication of Clinical Data Demonstrating EVK-001 Notably Improves Symptoms in Women With Diabetic Gastroparesis,2015-06-24 08:30:00-04:00,EVOK,positive
447786.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest EPS Growth Forecast For Next 5 Years,2015-06-19 04:43:00-04:00,EVOK,positive
447787.0,Evoke Pharma Reports Q1 Loss $0.58 Vs Est Loss $0.55,2015-05-14 16:06:00-04:00,EVOK,negative
